Concourse Financial Group Securities’s Integra LifeSciences IART Stock Holding History

Concourse Financial Group Securities’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22	Closed	-$510	–	2309
2024 Q2	$641	Hold	22	–	–	﹤0.01%	2178
2024 Q1	$779	Hold	22	–	–	﹤0.01%	2168
2023 Q4	$958	Buy	+22	New	+$866	﹤0.01%	2118
2023 Q3	–	Sell	-24	Closed	-$1.01K	–	2360
2023 Q2	$987	Hold	24	–	–	﹤0.01%	2135
2023 Q1	$1.38K	Sell	24 -1	-4%	-$56	﹤0.01%	2120
2022 Q4	$1.4K	Buy	25 +3	+14%	+$153	﹤0.01%	2101
2022 Q3	$1K	Buy	+22	New	+$1.13K	﹤0.01%	1885

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concourse Financial Group Securities's IART Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 22 shares — an estimated $510 sold.

Concourse Financial Group Securities first reported a position in IART in Q3 2022 and held it in 7 quarters. The position peaked at $1.4K in Q4 2022. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Concourse Financial Group Securities reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
Concourse Financial Group Securities sold 22 Integra LifeSciences shares in Q3 2024, an estimated $510.
Concourse Financial Group Securities first reported a position in Integra LifeSciences in Q3 2022 and held it in 7 quarters.
Concourse Financial Group Securities's Integra LifeSciences position peaked at $1.4K in Q4 2022.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.